Mallinckrodt faces Chapter 11 appeals, enters parallel Irish examinership
Health insurance companies that are appealing pharma manufacturer Mallinckrodt’s recently-confirmed Chapter 11 plan, have failed to obtain a stay on distributions pending appeal, as a court in Ireland relied on a 2016 precedent to open up parallel proceedings and appoint a Grant Thornton managing director as examiner.
To read more
Subscribe to Global Restructuring Review
Register for limited access
Register to receive our newsletter and gain limited access to subscriber content.
Subscribe to unlock unlimited access
Get news, unique commentary, expert analysis and essential resources from the Global Restructuring Review experts.